Paul G. Ambrose
Paul G. Ambrose is President of the Institute for Clinical Pharmacodynamics (ICPD), Schenectady, New York, USA. He is also an Honorary Research Fellow in Infectious Diseases at the University of Oxford, Oxford, UK and Adjunct Associate Research Professor at the University at Buffalo, Buffalo, New York.
Dr. Ambrose’s areas of scientific inquiry primarily involve anti-infective translational science, with the goal of improving patient care through the application of pharmacokinetic-pharmacodynamic (PK-PD) principles. Dr. Ambrose is a member of the working group on ‘Skin and Skin Structure Infection-Community-Acquired Pneumonia’ for The Biomarkers Consortium at the National Institutes of Health, Bethesda, Maryland, USA and is a member of the ‘ReAct: Action on Antibiotic Resistance’ Working Group in Uppsala, Sweden. Moreover, Dr. Ambrose serves as the chairperson of the United States Antimicrobial Susceptibility Test Committee (USCAST). He is Editor of Antimicrobial Agents Chemotherapy. Dr. Ambrose is the author of over 120 peer-reviewed scientific publications and approximately 160 scientific abstracts. Dr. Ambrose has served as an Editor for four textbooks; most notably the 1st and 2nd Editions of Antimicrobial Pharmacodynamics in Theory and Clinical Practice.